Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Histiocytic Disorders and Treatments

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the classification, diagnosis, and treatment of histiocytic disorders, including Langerhans Cell Histiocytosis and Erdheim-Chester Disease. It explores the role of BRAF mutations, immunohistochemical approaches to classification, and consensus guidelines for clinical management. The papers also delve into the pathogenesis, molecular characterization, and therapy intensification for multisystem involvement.

70
Works

How has Histiocytic Disorders and Treatments's publication output changed over time?

ScholarIQpublication output · 2003–2021

Output grew0% over the shown period — from 1 works in 2003 to 1 in 2021.

1
2
2
1
2
1
1
1
1
1
2003200520122013201420152016201720182021

What are the most-cited papers on Histiocytic Disorders and Treatments?

ScholarIQmost cited works
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Jean‐François Emile, Oussama Abla, Sylvie Fraitag, AnnaCarin Horne, Julien Haroche, Jean Donadieu, Luis Requena‐Caballero, Michael B. Jordan, Omar Abdel‐Wahab, Carl E. Allen, Frédéric Charlotte, Eli L. Diamond, R. Maarten Egeler, Alain Fischer, Juana Gil Herrera, Jan‐Inge Henter, Filip Jankú, Miriam Mérad, Jennifer Picarsic, Carlos Rodríguez‐Galindo, Barret J. Rollins, Abdellatif Tazi, Robert Vassallo, Lawrence M. Weiss
Blood. 20161,582 CitationsOPEN ACCESS
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
Julien Haroche, Frédéric Charlotte, Laurent Arnaud, Andreas von Deimling, Zofia Hélias‐Rodzewicz, B. Hervier, Fleur Cohen‐Aubart, David Launay, Annette Lesot, Karima Mokhtari, Danielle Canioni, Louise Galmiche, Christian Rosé, Marc Schmalzing, Sandra Croockewit, Marianne Kambouchner, Marie-Christine Copin, Sylvie Fraitag, Felix Sahm, Nicole Brousse, Zahir Amoura, Jean Donadieu, Jean‐François Emile
Blood. 2012694 Citations
Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years
Riccardo Haupt, Milen Minkov, Itziar Astigarraga, Eva Schäfer, Vasanta Nanduri, Rima Jubran, R. Maarten Egeler, Gritta Janka, Dragan Mićić, Carlos Rodríguez‐Galindo, Stefaan Van Gool, Johannes Visser, Sheila Weitzman, Jean Donadieu, for the Euro Histio Network
Pediatric Blood & Cancer. 2012693 CitationsOPEN ACCESS
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
Oussama Abla, Eric D. Jacobsen, Jennifer Picarsic, Zdenka Křenová, Ronald Jaffe, Jean‐François Emile, Benjamin H. Durham, Jorge Braier, Frédéric Charlotte, Jean Donadieu, Fleur Cohen‐Aubart, Carlos Rodríguez‐Galindo, Carl E. Allen, James A. Whitlock, Sheila Weitzman, Kenneth L. McClain, Julien Haroche, Eli L. Diamond
Blood. 2018634 CitationsOPEN ACCESS
Clinical Outcomes of Pulmonary Langerhans'-Cell Histiocytosis in Adults
Robert Vassallo, Jay H. Ryu, Darrell R. Schroeder, Paul A. Decker, Andrew H. Limper
New England Journal of Medicine. 2002450 CitationsOPEN ACCESS

Where is Histiocytic Disorders and Treatments research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Histiocytic Disorders and Treatments is open access?

ScholarIQopen access share
53%OPEN ACCESS
Gold
7%
Green
7%
Hybrid
7%
Bronze
33%
Closed
47%

Related on ScholarIQ

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]
Paper
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Paper
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Paper
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Paper
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
Paper
Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years
Paper
470M+ articles · free account